Ferrocene–indole hybrids for cancer and malaria therapy
Authors:
- 1 March 2011
- journal article
- conference paper
- Published by Elsevier in Journal of Organometallic Chemistry
- Vol. 696 (5) , 1011-1017
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Anticancer agents against malaria: time to revisit?Trends in Parasitology, 2010
- CoMFA and docking studies of 2-phenylindole derivatives with anticancer activityEuropean Journal of Medicinal Chemistry, 2009
- Plasmodium falciparumNa+/H+Exchanger 1 Transporter Is Involved in Reduced Susceptibility to QuinineAntimicrobial Agents and Chemotherapy, 2009
- Comparative QSAR modelling of 2-phenylindole-3-carbaldehyde derivatives as potential antimitotic agentsBioorganic & Medicinal Chemistry Letters, 2009
- Bioorganometallic chemistry—from teaching paradigms to medicinal applicationsChemical Society Reviews, 2008
- Ferroquine, an Ingenious Antimalarial Drug –Thoughts on the Mechanism of ActionMolecules, 2008
- Reactivity and Antiproliferative Activity of Ferrocenyl–Tamoxifen Adducts with Cyclodextrins against Hormone‐Independent Breast‐Cancer Cell LinesChemistry – A European Journal, 2008
- Ferrocifens and Ferrocifenols as New Potential Weapons against Breast CancerChimia, 2007
- On the medicinal chemistry of ferroceneApplied Organometallic Chemistry, 2007
- Binding of Organometallic Ruthenium(II) and Osmium(II) Complexes to an Oligonucleotide: A Combined Mass Spectrometric and Theoretical StudyOrganometallics, 2005